Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
4.060
+0.520 (14.69%)
At close: Apr 2, 2025, 4:00 PM
4.210
+0.150 (3.69%)
After-hours: Apr 2, 2025, 7:05 PM EDT

Karyopharm Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3485993854861,139
Upgrade
Market Cap Growth
-13.86%-13.86%-74.26%-20.76%-57.36%-5.35%
Upgrade
Enterprise Value
1932202015495951,079
Upgrade
Last Close Price
4.0610.1412.9751.0096.45232.20
Upgrade
PS Ratio
0.230.590.682.452.3210.54
Upgrade
PB Ratio
-0.18-0.46-0.73-23.11-6.1022.54
Upgrade
P/TBV Ratio
-----22.54
Upgrade
EV/Sales Ratio
1.331.511.383.502.849.99
Upgrade
Debt / Equity Ratio
-1.44-1.44-2.27-18.72-3.944.04
Upgrade
Asset Turnover
0.720.720.490.470.680.36
Upgrade
Inventory Turnover
1.541.541.361.251.011.81
Upgrade
Quick Ratio
1.511.513.165.053.434.35
Upgrade
Current Ratio
1.701.703.375.313.744.59
Upgrade
Return on Equity (ROE)
------391.29%
Upgrade
Return on Assets (ROA)
-36.88%-36.88%-27.05%-26.79%-19.86%-35.33%
Upgrade
Return on Capital (ROIC)
-58.48%-58.48%-34.57%-33.60%-25.14%-42.72%
Upgrade
Earnings Yield
-223.66%-89.55%-144.44%-42.94%-25.55%-17.23%
Upgrade
FCF Yield
-373.52%-149.55%-93.59%-38.88%-22.09%-14.08%
Upgrade
Buyback Yield / Dilution
-11.02%-11.02%-39.51%-8.85%-4.41%-16.28%
Upgrade
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q